Table 2.

Association between post-ESRD all-cause mortality and type of revascularization (CABG vs PCI (reference)) using Cox proportional hazards models

Models	Patients/Events	HR	95% CI	p-value
Model-1	964/523	0.74	0.62–0.88	p=0.001
Model-2	915/498	0.72	0.60–0.86	p<0.001
Model-3	893/481	0.65	0.53–0.80	p<0.001
Model-4	891/480	0.66	0.51–0.86	p=0.002

Data are presented as odd ratio (95% CI) unless otherwise specified.

Models are as follows:

Model 1: adjusted for time between procedure and ESRD initiation;

Model 2: additionally adjusted for demographics (age, sex, race/ethnicity, marital status and income);

Model 3: additionally adjusted for comorbidities (diabetes, malignancy, liver diseases, hypertension, ischemic heart disease, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, connective tissue disease, peptic ulcer disease, anemia, atrial fibrillation, depression, hyperlipidemia), eGFR and BMI;

Model 4: additionally adjusted for medications (anticoagulants, thrombolytic, aspirin, digitalis, beta-blockers, alpha-blockers, CCBs, antianginals, statins, vasodilators, thiazide diuretics, loop diuretics, potassium sparing diuretics, ACEIs/ARBs, radiocontrast and antidiabetics), procedure type (single- vs. multi-vessel).

Abbreviations: ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BP, blood pressure; CABG, coronary artery bypass grafting; eGFR, estimated glomerular filtration rate; PCI, percutaneous coronary interventions; ESRD, end-stage renal disease.